Archive for the ‘Lyme’ Category

Illinois Expands Insurance Coverage For Those With Tick-borne Diseases And Children Requiring EpiPens

https://wgem.com/2019/08/13/illinois-expands-insurance-coverage-for-those-with-tick-borne-diseases-and-children-requiring-epipens/?

Illinois expands insurance coverage for those with tick-borne diseases and children requiring EpiPens

SPRINGFIELD, IL (WGEM) — Governor JB Pritzker signed two new laws expanding insurance coverage for children whose allergies require life-saving EpiPens and Illinoisans suffering from Lyme disease.

“This legislation takes a big step forward in protecting our children and families,” said Pritzker. “Both of these new laws fulfill a core principle of this administration: state government ought to be standing up for working families. Lowering the cost of prescription drugs and expanding health care coverage is one important way to help lower costs and build a higher standard of living for all Illinoisans.”

The new laws include House Bill 889 and 3435.

House Bill 889

The Governor’s office stated that House Bill 889 requires insurance companies to cover office visits, testing and treatment for tick-borne diseases like Lyme disease. The new law aims to support farmers throughout the state who have struggled to afford continuing treatments. From 2004 to 2016, tick-borne diseases have risen dramatically according to the Centers for Disease Control.

“The ability to receive treatment when you have previously been insufficiently treated is life changing,” said Rep. Daniel Swanson (R-Woodhull). “By mandating insurance coverage of long-term antibiotic treatment needed for patients, we are putting another piece of the puzzle into place for some patients and removing one additional hassle on their path to recovery.”

House Bill 3435

Officials stated that House Bill 3435 requires insurance companies to cover EpiPens, for children with severe allergies. The cost of an EpiPen has skyrocketed over the last decade, rising by more than 400% for the two-pen injector pack. Without insurance, these EpiPens can cost a family nearly $700 and typically have a shelf life of a little more than a year before the medicine needs to be restocked in stores.

“With steady increases in food allergies and other serious allergic conditions, families are relying on EpiPens more than ever before,” said Sen. Julie Morrison (D-Deerfield). “We should be doing everything we can to expand access to affordable lifesaving drugs and medicines. No child with a serious allergy should be without an epinephrine injector because they cannot afford one.”

House Bill 889 takes effect immediately.

House Bill 3435 takes effect on January 1, 2020.

__________________
**Comment**
While legislators attempt to help Lyme patients by proposing bills such as these, the CDC Lyme Corps goes into every state and undermines them:  https://madisonarealymesupportgroup.com/2017/07/07/cdc-sabotages-state-laws-protecting-lyme-patients/  Excerpts: 
To be clear, the CDC is using Lyme Corps to tell health practitioners the only valid treatment for Lyme, chronic Lyme and complications from coinfections are found in the 2006 IDSA Lyme Guidelines.  However, key science institutions and federal agencies would not support this objective….
The CDC Lyme Corps was initiated in 2013 prior to the NGC delisting of the IDSA Lyme Guidelines. Nevertheless, as of July 4, 2016, the IDSA and the CDC Lyme policy and programs, including Lyme Corps continue to promote these outdated notions and noncompliant Guidelines.
The IDSA has also taken numerous actions against Lyme patients’ and practitioners’ protections.  One such IDSA website post  State-Level Lyme Disease Advocacy Efforts  openly admits to undermining Lyme patient rights in: California, Connecticut, Maine, Maryland, Massachusetts, Minnesota, Nebraska, New Hampshire, New Jersey, New York, Ohio, Oregon, Pennsylvania, Rhode Island, Texas, Vermont, Virginia, West Virginia and Wisconsin. [xvi]  Another such IDSA web announcement is the IDSA’s Lyme Disease Advocacy Efforts. [xvii] The ‘anti-protections’ advocacy letters are detailed.

A breach of public trust by the CDC Directors responsible for protecting the public health and welfare against Lyme epidemic – all these CDC officials are members of IDSA and there are no non-IDSA members among the Directors responsible for CDC’s Lyme policy and programs.  [xxviii]

This group of CDC officials show continuous and singular “preferential treatment” for the ‘Lyme product’ of a private medical society, the IDSA. The product is the IDSA Lyme Guidelines; these Guidelines have failed federal criteria for evidence-based medicine.

The promotion of these federally noncompliant IDSA Guidelines make waste of tax dollars and misinform the public. Such actions run contrary to protecting the health and welfare of the public against the Lyme epidemic and they show a strong a lack of “honest effort in the performance of their duties.”

Unfortunately, due to this undermining, I do not expect these well meaning bills to do anything of substance to truly help patients.
Regarding “doctor protection” bills, I’ve heard from doctors that they are under more scrutiny than before they had these supposed “protections.”
And regarding states that have adopted bills requiring doctors to tell patients they could still be infected even if the test is negative, I’ve heard many doctors aren’t complying.

 

 

Public Hearing Tomorrow (Aug. 15, 2019) Two WI Bills on Tick Prevention

I apologize for this late notice.  I just received it myself. I was told the two Lyme bills would be presented around noon.

https://docs.legis.wisconsin.gov/raw/cid/1509726

Assembly

PUBLIC HEARING Committee on Environment

The committee will hold a public hearing on the following items at the time specified below:

Thursday, August 15, 2019 11:00 AM
412 East

Assembly Bill 190

Relating to: wetland mitigation banks, providing an exemption from emergency rule procedures, providing an exemption from rule-making procedures, and requiring the exercise of rule-making authority.

By Representatives Tusler, Ohnstad, Sinicki, Kerkman and Mursau; cosponsored by Senators Wanggaard, Cowles, Wirch and Olsen.

Assembly Bill 210

Relating to: time limits for correcting violations found by the environmental compliance audit program.

By Representatives Brooks, Brandtjen, Knodl, Kulp, Skowronski, Tusler and Wichgers; cosponsored by Senators Jacque, Cowles and Miller.

Assembly Bill 297

Relating to: changes to the electronic waste recycling program and granting rule- making authority.

By Representatives Mursau, Hebl, Anderson, Ballweg, Billings, Ohnstad, Shankland, Sinicki, Skowronski, Spreitzer, Stubbs, Tusler, Vruwink, Spiros and Subeck; cosponsored by Senators Miller, Cowles, Larson, Smith, L. Taylor, Wirch and Carpenter.

Assembly Bill 315

Relating to: signs informing about Lyme disease in state parks, state trails, state recreational areas, and state forests and making an appropriation.

By Representatives Mursau, Milroy, Anderson, Considine, Crowley, Edming, Emerson, Gruszynski, Hesselbein, Kulp, B. Meyers, Ohnstad, Ott, Pope, Ramthun, Rodriguez, Sargent, Shankland, Sinicki, Snyder, Spiros, Spreitzer, Tauchen, C. Taylor, Thiesfeldt, Tusler and Rohrkaste; cosponsored by Senators Cowles, Miller, Carpenter, Hansen, Larson, Olsen, Petrowski, Ringhand and Smith.

Assembly Bill 316

Relating to: making insect repellant available for sale in state parks and state forests.

By Representatives Mursau, Milroy, Anderson, Crowley, Edming, Emerson, Gruszynski, Hesselbein, Kulp, B. Meyers, Ohnstad, Ott, Pope, Ramthun, Shankland, Sinicki, Snyder, Spiros, Spreitzer, Tauchen, C. Taylor, Thiesfeldt, Tusler and Rohrkaste; cosponsored by Senators Cowles, Miller, Carpenter, Hansen, Larson, Olsen, Petrowski, Ringhand and Smith.

Representative Joel Kitchens Chair

__________________

For more on the bills:  https://madisonarealymesupportgroup.com/wp-content/uploads/2019/05/time-to-bite-back-against-lyme-disease-05-23-19.pdf

News story on bills:  https://madisonarealymesupportgroup.com/2019/06/01/news-story-update-lawmakers-introduce-package-of-bills-aimed-at-lyme-awareness-in-wisconsin/

https://madisonarealymesupportgroup.com/2019/06/30/lawmakers-want-to-combat-lyme-disease-with-more-signs-insect-repellent-in-public-parks/

 

My Chronic Lyme, Your Ill-Informed Summertime Clickbait

https://medium.com/news-to-table/my-chronic-lyme-your-ill-informed-summertime-clickbait

My Chronic Lyme, Your Ill-Informed Summertime Clickbait

Aug 1
Coverage of Lyme disease often ignores science, vilifies alternative practitioners, and ridicules patients. And it’s making a bad crisis worse.
Cases of Lyme disease have been on the rise around the country for decades, with most reported in the northeast and upper Midwest. (Map credit: The Cary Institute of Ecosystem Studies)

By Lauren Rothman

This summer, as people take to the outdoors to hike, camp, fish and swim, news outlets across the country are united in their exhortations to be on the alert for ticks, the tiny arachnids whose bite can confer a host of illnesses, of which Lyme disease is the best-known and most widely feared. A quick Google News search for “ticks” brings up recent results from Self, The Atlantic, TIME and a variety of local news channels, all urging tick checks and sharing information on the many types of tick borne diseases. Tick populations are on the rise, these articles warn us; the illnesses they carry can be deadly, the chorus relates.

Generally, even the most headline-grabbing article on tick-borne diseases will end on an optimistic note, claiming that the majority of these illnesses are readily diagnosed and easily treated with a round of antibiotics. Such conclusions fly in the face of the experience of those who believe they suffer from so-called “chronic” Lyme disease — also called Post-Treatment Lyme Disease Syndrome (PTLDS) — an estimated ten to 20 percent of the population that continues to experience the symptoms of Lyme even after taking the Centers for Disease Control (CDC)-sanctioned treatment of two to three weeks of antibiotics.

For a disease as complex as Lyme, in which symptoms are diffuse, diagnostic testing is unreliable and treatments range from the conventional to the Wild West of alternative medicine, any black-and-white decree on how best identify and cure the disease is likely to remain elusive. But for patients — and I count myself among them, having fallen ill with Lyme after a trip to the Catskills two years ago — the shortcomings of most service journalism articles on Lyme are minor compared to two community-roiling pieces published this summer by the New York Times and New York Magazine. In the first, science writer Apoorva Mandavilli relates the story of her son contracting Lyme disease and quickly vanquishing it with a round of antibiotics; she concludes that Lyme is “an easily treated infection with no long-term consequences for children, or even the vast majority of adults.” In the second, journalist Molly Fischer takes a Gonzo-style dive into chronic Lyme, speaking with patients and attending support groups. Her thesis is that the disease has “grown into a phenomenon often untethered from scientific method or peer review.”

Taken together — and published within weeks of each other — these two misreported, factually inaccurate and seemingly bias-laden articles have heaped fuel upon the evidently inextinguishable fire of the so-called “Lyme Wars,” pitting those who don’t believe that Lyme can become chronic against those who are sure that it does. Within hours of its publishing, Mandavilli’s article — an op-ed entitled “My Son Got Lyme Disease. He’s Totally Fine” — had launched a heated online debate, with sufferers of chronic Lyme dismantling the article’s many errors on Instagram, Twitterand in its comments section, which eventually garnered more than 700 posts. Fischer’s examination of the chronic Lyme “community,” entitled “Maybe It’s Lyme: What Happens When an Illness Becomes An Identity?” paints sufferers as a naive group susceptible to charlatan doctors and snake-oil treatments, and ignited a similar response on Instagram, Twitter and elsewhere.

The lively debate around these two pieces testifies to a growing community that is pushing back against the use of chronic Lyme as clickbait. And make no mistake, this community is real and growing. Peer-reviewed scientific studies increasingly confirm the existence of PTLDS; Brown University statisticians recently predicted that by 2020, the population of sufferers in the U.S. will reach nearly 2 million.

The great Lyme Wars are just beginning.

Jenny Lelwica Buttaccio is a Chicago-based journalist who was diagnosed with Lyme in 2012, and has covered tick borne diseases for outlets including Real Simple, Prevention, and ravishly. She notes that when it comes to one-sided coverage of Lyme, articles like those from the Times and New York are nothing new. While Buttaccio said she has noticed cycles of coverage about the disease — in 2015 and 2016, “nobody wanted to hear about it”; then in 2017 and 2018, coverage ramped up again —there have always been inflammatory pieces that, at best, misrepresent Lyme and its symptoms and, at worst, slander its sufferers.

Specifically, Buttaccio recalled a 2016 VICE News article entitled, “If You Think You Have Chronic Lyme Disease, Most Doctors Say You’re Wrong.” The article characterizes so-called “Lyme-literate” doctors as “quacks” and focuses on the possible negative health outcomes of the long-term antibiotic treatment they often prescribe for chronic Lyme. She remembered that the article began as a dialogue between a group of journalists affected by Lyme and some editors at VICE, a situation that initially seemed hopeful until the actual article, authored by Sydney Lubkin in partnership with the medical news service MedPage Today, appeared.

“Everybody was appalled,” Buttaccio told me.“It was like, you were just talking to journalists about this subject, and now you went in the opposite direction?”

Just as the uproar over the VICE piece died down, yet another “anti-Lyme” piece was published in the Washington Post. Written by staff writer Lena H. Sun, “Dangerous unproven treatments for ‘chronic Lyme disease’ are on the rise” downplayed the severity of PTLDS symptoms and emphasized the wacky nature of unproven alternative treatments such as IV hydrogen peroxide, garlic supplements and stem cell transplants.

“It was a similar thing to the New York Times’ in that it was just a hatchet job on Lyme disease,” Buttaccio said. “It was like every wrong thing, smashed into one piece. They just got blasted for it.”

Given her memory of past articles that misrepresented Lyme disease and the struggles its sufferers face, Buttaccio said she wasn’t surprised when she first read Mandavilli’s Times piece.

“When you see that year after year after year, from different people, it’s always a mixed bag of emotions,” said Buttaccio, who took to Twitter to systematically dismantle each false and scientifically unsupported claim in the recent Times piece. “On one hand, you’re laughing, because it’s absurd. On the other hand, I always feel bad for patients who are harmed by this misinformation, and the people who potentially could be harmed in the future with such a cavalier approach to Lyme.”

As I do, Buttaccio believes that what articles on Lyme lack is nuance. Not every article has to toe the CDC-sanctioned line of “easily diagnosed, easily treated”; nor, at the other end of the spectrum, does every article have to tout the curative powers of stevia sugar substitute. In order to accurately reflect the experiences of those who live with chronic Lyme, the media has to do a better job finding gray-area stories between black and white.

“There should be people who want to check the accuracy of a diagnosis and who want to lean on science — those are good things,” Buttaccio said. “But you have to balance a little bit of that with what thousands of people are saying. There has to be something in your mind that goes, ‘Maybe we don’t have all the information we need. Maybe we do have some gaps to fill. Maybe it’s not as simple as we’re making it.’ And it seems like we never quite get to that place.”


Unless it can find some balance, the media runs two risks. One is undermining public trust, as evidenced by the many Times and New York readers who barraged both publications with Letters to the Editor, or stated that they would cancel their memberships, over their Lyme coverage. The other risk concerns losing much-needed contributions by the varied, and valuable, members of the Lyme community.

Jordan Younger, the influential blogger and Instagrammer known as The Balanced Blonde, has been sharing her struggle with Lyme disease since she was diagnosed last summer. Younger was interviewed extensively for the New York article, and is unflatteringly portrayed by its author Fischer as a wishy-washy Valley Girl hopping from expensive Beverly Hills doctor to expensive Beverly Hills doctor and leveraging her illness to gain more exposure for her brand.

“If you are an editor, assign Lyme pieces to people who have and understand Lyme please. Many of us are writers”: Porochista Khakpour, whose memoir, Sick, explores her experience with chronic Lyme.

“Lyme has also brought the Balanced Blonde to a new audience,” the article reads. “Instagram is home to an active Lyme community, and many of Younger’s photos are now hashtagged #lymewarrior; they receive hundreds of comments and thousands of likes. Target is among Younger’s sponsors, suggesting that perhaps Lyme content isn’t a bad way to reach wellness-minded American women. ‘Jordan younger lyme disease’ is among Google’s top suggested searches for her name, along with ‘jordan younger age’ and ‘jordan younger net worth.’”

Younger, who shared her outrage at what she said was a mischaracterization and manipulation of her conversation with Fischer both on Instagram and in a dedicated blog post, has written that, as a result of the experience, she will never speak to the media about Lyme disease again. Whatever your opinion — or lack thereof — of Younger and her brand, she’s a vocal member of the Lyme community who raises awareness of the disease, and now her voice on the matter has been silenced.

Another member of the chronic Lyme community who expressed her outrage with the New York piece is Porochista Khakpour, the acclaimed author of the 2018 memoir Sick, which chronicles her long battle with the disease. After the article’s publication, Khakpour took to Twitter to denounce it.

“Wish there would be a moratorium on Lyme pieces until they could figure out why people with Lyme disease are so hated and ridiculed,” she wrote on July 25.

Khakpour also expressed the need for a better diversity of voices when it comes to covering Lyme.

“If you are an editor, assign Lyme pieces to people who have and understand Lyme please. Many of us are writers.”

While Jenny Buttaccio, the journalist, expressly stated that she doesn’t believe that only journalists with Lyme have the right to cover it, more thorough communication with the Lyme community is precisely what she argues for as a step towards righting the ship.

“If you haven’t dealt with it personally, and you are a journalist and you want to write on the subject, you should tap into some of the places that the community itself goes to for valuable information,” she advised. “It isn’t always as easy as looking stuff up on Google. Don’t be afraid to look at both sides of the issue. You can do it in a diplomatic way.”

As it stands now, media coverage of chronic Lyme often ignores science, vilifies alternative practitioners, and ridicules patients. As a journalist, and as a sufferer of the disease, I argue that we need to do better. This is about much more than just bruised egos.

“When you dismiss or diminish the challenges that go along with a diagnosis, sure, it hurts people’s feelings,” Buttaccio said. “But more so, it takes us a step back from actually helping people.”

Lauren Rothman is a freelance journalist and a native of Brooklyn. Follow her on Instagram @laurenoliviarothman and @laurenstingslyme.

 

Vermont’s No. 2 Ranking For Lyme Disease Prompts Concerns

https://vtdigger.org/2019/06/16/high-tick-populations-prompt-lyme-disease-concerns/

Vermont’s No. 2 ranking for Lyme disease prompts concerns

tickA blacklegged tick, commonly known as a deer tick. Photo courtesy of Vermont Department of Health

Vermont currently ranks No. 2 in the country for Lyme disease — though many years, it’s No. 1. The CDC considers the disease endemic in the state.

Critics of the medical establishment, however, believe there is another problem contributing to the high incidence of the disease in Vermont: A lack of effective early diagnosis and treatment.

In 2017, there were 1,093 cases, according to the Vermont Department of Health. Data from 2018 hasn’t been finalized yet, but according to Natalie Kwit, the state public health veterinarian, there were likely approximately 500 to 600 cases, which she described as a normal year-to-year variance.

Other tick-borne diseases, like Babesiosis and Anaplasmosis, are also on the rise in Vermont, Kwit said. Since Vermont is on the northern edge of the area affected by tick-borne illnesses, the lower half of the state gets hit hardest. According to Kwit, Bennington County has the highest incidence of Lyme disease, followed by Rutland, Windsor, Windham, Addison and Grand Isle Counties.

Kwit said it’s hard to say how bad this year will be, but noted that with the ticks in their nymph form right now — when Lyme disease rates are highest — Vermonters should be particularly careful through June and July.

Bill Landesman, who researches ticks at Green Mountain College, said Vermont is kind of a perfect storm for Lyme rates. Not only are the black-legged ticks that populate the area ideal hosts for Borrelia burgdorferi, the bacteria that causes Lyme — the state also has plentiful numbers of white-tailed deer and deer mice, two primary tick carriers.

Landesman said the infection rate for nymphs, which are currently in season, is around 20% to 30%, while the adult rate, in season later in the summer, is twice that, 40% to 60%. He said on some of the sites he studies, there is a one in four chance that you’ll find a tick in any given square meter — meaning if you go on a hike through the woods, you’re at risk for Lyme.

Critics say the Lyme problem in Vermont isn’t just the result of a high tick incidence. They question whether the medical community could do more to respond to the endemic.

Medical professionals acknowledge that Lyme can be frustrating to diagnose.

Prompt diagnosis as prevention

Rebecca Zelis’ son didn’t have the bullseye rash or joint pain that doctors tend to look for to identify Lyme disease. But his symptoms presented behaviorally. By the time he reached kindergarten, Zelis said his symptoms were deeply troubling.

“Mommy I just want to die,” he told her. “I want to run in front of a car and die.”

Diagnoses for her son ranged from psychological problems to bad parenting. It wasn’t until her son started to get more classic symptoms, like headaches and chronic infections, that doctors finally recognized he had Lyme disease.

Since he went so long without treatment, there was a long road back to neurological recovery. He was homeschooled for a while in middle school because he was too sick to leave the house.

When Zelis looked online for more information, she found a lot about prevention, but not as much about symptoms, especially less typical symptoms like the ones her son was experiencing. So in 2015, she started VTLyme.org — now a nonprofit — to help other Vermonters navigate the disease and other tick-borne illnesses.

When caught early and treated effectively, Zelis said, Lyme disease typically won’t cause long term problems. But oftentimes, that isn’t the case.

“Not all medical providers in Vermont know how to accurately diagnose and effectively treat tick-borne diseases,” Zelis said. “Vermonters affected by complex tick-borne diseases need more resources, understanding and support.”

In 2014, Zelis said more than half of the children diagnosed with Lyme disease in Vermont did not have a bullseye rash, but all of the medical information she was seeing still centered around that symptom. The Center for Disease Control reports that nationally between 70% and 80% of Lyme disease cases involve a bullseye rash. But Zelis cautions that local variances can get forgotten among the broader national conversations.

She said in the past two months, patients have told her they haven’t received accurate information from doctors. In one case, a woman wrote to her about a friend’s child who was bitten by a tick and was told to wait, and if the child didn’t get a bullseye rash, they were in the clear. Another message was from a parent whose son had a bullseye rash after they got back from a camping trip, but was told by his doctor that as long as he had no other symptoms, he didn’t need to worry — though within a year, the child had almost every known symptom of Lyme.

“I would argue that accurate and prompt diagnosis is a form of prevention,” said Zelis, who is studying for a mental health degree with the aim of helping people affected by Lyme disease. “It’s preventing people from having a more complex and severe form of the disease.”

Seeking treatment

A little over a year ago, Monika Reis of Montpelier noticed an immature tick, called a nymph, lodged in her neck. She later saw a rash, though not the typical bullseye. She went to Plainfield Health Center, where a doctor took a picture of the rash and did blood work — which came back negative for Lyme. Within a week, she had night sweats that were so intense she checked the ceiling to see if there was a leak.

“I had it full on within two weeks. There’s no manufacturing that experience,” Reis said.

So she went back to the doctor, who decided to treat it as Lyme, even though her blood work wasn’t conclusive.

Reis’ experience was in contrast to friends who she knew were in similar situations, but whose doctors didn’t immediately treat it that way.

“We throw antibiotics at children 12 times before they’re 7 for earaches, and suddenly, an adult with a strong feeling and a photo of rash comes in, and you’re not going to treat for Lyme?” Reis said. “There’s a real problem here with the resistance to thinking that it’s Lyme.”

In addition to taking doxycycline, the antibiotic typically used to treat Lyme, Reis used herbal remedies and acupuncture. Several of her friends with Lyme regularly go out of state just to see specialists.

Reis stressed that people who suspect they have Lyme have to be assertive about their treatment.

“Even within my own story that’s true,” Reis said. “If someone is not willing to treat you, I’d highly recommend going to another person within a few days, or even a naturopath — somebody that is going to be empathetic to your situation and not have this blocked mentality about it.”

A state law passed in 2014 gave doctors more latitude in their treatment of Lyme by allowing them to treat outside of the guidelines set by the Infectious Disease Society of America.

But Rachel Nevitt, who advocated for the bill, believes Vermont’s response to the disease is badly outdated.

“The truth of the matter is providers here are clueless,” Nevitt said. “Some are catching on, but those catching on are afraid to treat it the way it needs to be treated because the medical boards will come after them.”

Nevitt had likely had the disease for years before she was finally diagnosed. In 2009, Nevitt suddenly fell to the floor with excruciating spinal pain. She presented like she had a herniated disc, but had no precipitating accident, and an MRI showed up normal. Today, Nevitt said, people know that means Lyme. But back then, it was just another bullet point in her laundry list of symptoms she couldn’t explain.

Nevitt was becoming dyslexic, forgetful, and losing spatial awareness. Once, she accused her husband of spending $80,000 on a new irrigation system for their farm simply because she couldn’t recognize the irrigation system that they’d been using for years.

It wasn’t until her farm manager tested positive for the disease and told Nevitt she should get tested that she began to even consider Lyme. But Nevitt knew she never saw a tick bite, and never had a rash — she couldn’t have Lyme. It took weeks before she finally realized, “Oh my God, that’s what I have.”

But even then, she struggled to get a diagnosis — or even get tested. Nevitt didn’t find treatment until she left the state to see a specialist in the Hudson River Valley.

“At that point, I really realized everything that people who have Lyme say is true,” she said. “Something is wrong with the medical community, they just think we’re all crazy.”

One thing that’s common with Lyme patients, Nevitt said, is that at some point, a stressful life event causes their symptoms to get very bad very quickly. She said for a lot of people, it can be something tragic like the loss of a child or a divorce. Nevitt said in her case, it was when her husband, now-Lt. Gov. David Zuckerman, ran for state Senate in 2012, which left her to run their organic farm alone.

Vermont’s Lyme research is 20 years behind, she said.

“Name one disease that they’re relying on that old of research for,” Nevitt said. “If you talk to anybody with Lyme, they’ll tell you the medical community here is woefully far behind.”

Frustrating for doctors and patients

“When we don’t understand the mechanisms for something, it’s very frustrating for patients and very frustrating for us.”– UVM Medical Center Rheumatologist Ralph Budd.

Doctors acknowledge that they don’t have all the answers on Lyme disease.

Ralph Budd, a rheumatologist at UVM Medical Center who specializes in Lyme-linked arthritis, said people are often convinced that if they have symptoms, they also have an ongoing infection, though that often isn’t the case. He said treating symptoms tends to be a very effective option once the infection period has passed.

“When we don’t understand the mechanisms for something, it’s very frustrating for patients and very frustrating for us,” Budd said. “Medicine has many of those — Lyme is not the only one.”

Budd is wary of specialized labs that cater to Lyme testing. He said unlike the tests he uses, which need the Lyme antibodies to develop for six weeks before they are accurate, other labs have faster tests that he says have been proven to return a higher rate of false positives.

“When patients think they have something, and they’re not feeling well, of course they shop around and look for something to help,” Budd said. “But if the lab gives them falsely positive results, that can really do a disservice to the medical community.”

Kwit, of the Vermont Department of Health, echoed this sentiment.

“It is important to correctly diagnose Lyme disease when someone has it. But it is equally important not to misdiagnose someone with Lyme disease when the cause is really something else,” she said.

A misdiagnosis of Lyme disease could lead to a long road of treatment that doesn’t work, and could result in an illness that lasts longer, she said. She urges the use of validated, evidence-based methods to diagnose the disease.

There’s currently a rift in the Lyme community over the best ways to address the disease. Some advocates are looking to guidelines put out by the International Lyme and Associated Diseases Society, which they believe are more accurate ways to test. But those standards are not endorsed by the Centers for Disease Control and are regarded with skepticism by many in the medical community.

Alexis Chesney, a naturopathic Lyme specialist, said the best way to address Lyme is to prevent it.

She pointed out a number of recommendations to help prevent the disease’s spread, including treating clothes with tick repellent, showering within two hours of being outdoors, checking pets to make sure they don’t carry ticks inside, and drying clothes on hot for 10 minutes as soon as you get inside to make sure any ticks — which are often as small as poppy seeds — are gone.

“I would love for people to stop getting tick bites,” Chesney said. “Then we could really solve this tick epidemic.”

_________________

**Comment**

Those getting the rash varies from 25-80% – hardly something to bank on. The myth that everyone gets the “classic” EM rash needs to be dropped like a bad habit.

The skepticism of smaller CLIA-certified labs is unwarranted. They undergo the most strenuous lab requirements and specialize in bacteriology and virology. Lyme has always been a clinical diagnosis.

Being told to “wait and see” after a tick bite is asinine. Insanity is doing the same thing over and over and expecting different results. We all know early treatment is everything – SO, WHY WAIT?

Doctors desperately need to become educated on tick borne illness.  And yes, Lyme/MSIDS can cause psychological symptoms:  https://madisonarealymesupportgroup.com/2018/08/25/neuropsychiatric-lyme-borreliosis-an-overview-with-a-focus-on-a-specialty-psychiatrists-clinical-practice/

https://madisonarealymesupportgroup.com/2015/10/18/psychiatric-lymemsids/

https://madisonarealymesupportgroup.com/2019/02/16/lyme-is-all-in-your-head-a-wake-up-call-to-mental-health-professionals/

The fact doctors are STILL afraid to treat patients is telling. This is wrong on so many levels and indicates a huge problem: https://madisonarealymesupportgroup.com/2018/12/15/everything-about-lyme-disease-is-steeped-in-controversy-now-some-doctors-are-too-afraid-to-treat-patients/

Do you hear of doctors being afraid to treat diabetes, cancer, or syphilis?

No. Why? Because insurance companies aren’t pulling strings on those diseases.

Managed care is the problem: https://madisonarealymesupportgroup.com/2017/08/19/dr-liegner-guidelines-used-by-managed-care-causing-lyme-deaths/

https://madisonarealymesupportgroup.com/2019/08/01/why-we-need-to-stop-treating-lyme-disease-like-a-typical-infectious-disease/

https://madisonarealymesupportgroup.com/2018/06/14/corruption-human-rights-violations-against-lyme-doctors-scientists-and-parents-now-on-united-nations-record/

 

 

 

Lyme Disease: The CDC’s Greatest Coverup & What They Don’t Want You To Know

https://www.wakingtimes.com/2019/07/09/lyme-disease-the-cdcs-greatest-coverup-what-they-dont-want-you-to-know-evidence-of-sexual-transmission/?

LYME DISEASE: THE CDC’S GREATEST COVERUP & WHAT THEY DON’T WANT YOU TO KNOW

Lyme Disease: The CDC’s Greatest Coverup & What They Don’t Want You To Know

Organic Olivia, Guest
Waking Times

Lyme Disease. Do you have it?

If you did, you probably would not know, unless you’re one of the chronic sufferers that had to visit over 30 doctors to get properly diagnosed. Lyme disease tests are highly inaccurate. They’re often inconclusive or false negative. That’s because this clever bacteria has found a way to dumb down the immune system and white blood cells, so it is not detectable until treatment is initiated. To diagnose Lyme properly you must see a “Lyme Literate MD (LLMD)”, however, more and more doctors are turning their backs on patients due to sheer fear of losing their practices! Why? Because insurance companies and the CDC will do whatever it takes to stop Chronic Lyme Disease from being diagnosed, treated, or widely recognized as an increasingly common issue.

Lyme is considered “only” transmittable by a tick infected with bacteria. However, the CDC itself admits it is under-reported, and believes there are between 300,000 to half a million new cases each year. That makes Lyme disease almost twice as common as breast cancer and six times more common than HIV/AIDS.Where are all of these new cases coming from?

http://

Dr. Alan MacDonald, MD talks about Lyme.